Two years into a $49.5 million cancer-mapping project, researchers are opening the door to new kinds of tests that could alert doctors to multiple kinds of cancer when they’re most treatable.

A BME team is putting a synthetic flag on tumors, then engineering a patient’s immune cells to find and eliminate cancer.